The size of the complementary and alternative medicine market is an ‘indictment against the conventional medical industry,’ says F. Perry Wilson. What can be done to reverse this growing trend? Medscape
Author: Medscape
10 Ways Doctors Lose Patients and Respect on Social Media
Physicians often enjoy using social media for personal or professional reasons, but a single ill-considered post can drive patients away and could even threaten a career. Medscape Medical News
A Breakthrough Year in Retina Research
Dr Charles Wykoff highlights the many innovations in retina research in 2019, from the milestone moment of gene therapy to the diagnostic promise of artificial intelligence. Medscape Ophthalmology
15 Studies That Challenged Medical Dogma in 2019
Dr Eric J. Topol’s favorite scientific papers challenge medicine’s prevailing wisdom. These 15 papers from 2019 did just that. Medscape
FDA OKs Ophthalmic Stain for Vitreoretinal Surgery
Brilliant Blue G (0.025%) ophthalmic solution selectively stains the internal limiting membrane to distinguish it from the retina to facilitate removal. FDA Approvals
Achieving Adequate Pupil Size in Cataract Surgery
What are the best methods for managing small pupils in patients undergoing cataract surgery? Current Opinion in Ophthalmology
Blue Light Glasses: Helpful or Just Hype?
More people are turning to blue light glasses to block the light from digital screens. But do the glasses really work? WebMD Health News
MP-TSCPC: What We Do and Don’t Know
Can micropulse transscleral diode laser photocoagulation lower IOP and side effects associated with conventional transscleral diode treatment? Dr Shuchi Patel shares her personal observations. Medscape Ophthalmology
FDA Panel Thumbs Up for Teprotumumab for Thyroid Eye Disease
FDA panel unanimously recommends approval of teprotumumab for the treatment of active thyroid eye disease. ‘I think we’re finally going to be able to get a lot of people some help,’ said one member. Medscape Medical News
Brolucizumab Gets EU Panel Backing for Wet AMD
The treatment, previously approved by the FDA, offers less-frequent injections, and efficacy proven in two head-to-head global trials. International Approvals
It’s About Time: Brolucizumab Extends Treatment Effect in Wet AMD
The latest phase 3 results show why this drug may be the promising treatment we’ve been waiting for. Medscape Ophthalmology
‘Residents From Hell’: Indignities and Outcomes in Medical Training
A psychiatrist grapples with the often harsh realities of modern medical education. Medscape Psychiatry
Watching for Radiation Harm After Interventional Procedures
Staff and patients exposed to radiation during interventional procedures can experience lens opacities that differ from cataracts typically seen in clinical practice and with other skin injuries. Medscape Medical News
Visual Snow Syndrome a New Symptom of Migraine?
The first cases of episodic visual snow syndrome, which appears to occur only during a migraine attack, have been reported. Medscape Medical News
AI Screening for Diabetic Retinopathy Moves to Retail Clinics
The high-tech screening for diabetic retinopathy has already been added to five grocery stores in Delaware and Pennsylvania. Medscape Medical News
Peripheral Fields Key in Predicting Diabetic Retinopathy
A new artificial intelligence algorithm uses peripheral retinal field images to predict how quickly diabetic retinopathy will progress and which patients need immediate attention. Medscape Medical News
Public Commenting Has Been Hijacked by Biopharma
In a recent analysis, 1 in 2 ‘public commenters’ giving input on state-level drug coverage decisions was someone with financial ties to the pharmaceutical industry. Medscape Oncology
FDA OKs First Contact Lens to Slow Myopia in Children
MiSight (CooperVision Inc) soft, disposable contact lenses are meant to be worn daily (but not overnight) to correct nearsightedness and slow the progression of myopia in children 8 to 12 years old. FDA Approvals
Solving a Medical Mystery Crucial to Future Space Travel
Half the astronauts on the International Space Station have been held back by blurry vision, jeopardizing longer missions to Mars, and clinicians are racing to prevent the perplexing problem. Medscape Medical News
Double Trouble: 4 Things to Do in Patients With Diplopia
A guide for discerning whether the cause of new-onset diplopia is benign or potentially life-threatening. Medscape Ophthalmology